Dr. Juergen O. Boehm

Dr. Juergen O. Boehm has a diverse and extensive work experience in the medical technology industry. Dr. Juergen O. currently serves as the CEO & CMO at Hemovent GmbH since October 2022. Prior to this, they founded and served as the Managing Director of jb medtech medical consulting GmbH from March 2022.

From 2013 to 2021, Dr. Boehm held multiple roles at Xenios AG, including Chief Medical & Chief Operating Officer, CEO, Vorstand / Managing Director, and Chief Marketing & Chief Medical Officer. Dr. Juergen O. was a founding member of Xenios AG.

Between 2011 and 2021, they served as a Member of the Management Board and Medical Director at MEDOS Medizintechnik AG. Additionally, they were the Managing Director of Novalung GmbH from 2014 to 2019.

Dr. Boehm was also the President / Directeur Général at Xenios France from 2015 to 2018.

Dr. Juergen O.'searlier experience includes serving as the Clinical Director at MAQUET Cardiovascular from 2007 to 2011.

Dr. Juergen O. Boehm started their education journey in 1986, attending Ulm University for six years, until 1992. Dr. Juergen O. pursued a degree in Medicine during this time. Later, they continued their academic pursuits at the University of Tübingen where they attained the title of Privatdozent in the field of Cardiac Surgery. Unfortunately, the specific start and end years for this phase of their education are not mentioned.